This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.68% per year. These returns cover a period from January 1, 1988 through August 5, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
Zacks News
Monsanto (MON) Premium Herbicide Declared Non-Carcinogenic
by Zacks Equity Research
The National Cancer Institute recently announced that Monsanto Company's (MON) Roundup herbicide is non-cancerous.
Monsanto (MON) Upgraded to Buy on Robust Growth Drivers
by Zacks Equity Research
Bayer AG's buyout deal, strategic restructuring moves, strong innovation and elevated demand for crop-yield enhancing products anticipated to drive Monsanto's (MON) near-term growth.
Will Oil Price Volatility Affect These Agriculture Stocks?
by Zacks Equity Research
Hike in crude oil price raises cost of producing agricultural products and results in higher food prices and vice versa. Also, use of biofuel will boost demand for feedstock like corn and sugar.
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Syngenta, Albemarle and Monsanto
by Zacks Equity Research
Zacks Industry Outlook Highlights: Dow Chemical, DuPont, Syngenta, Albemarle and Monsanto
Chemical Industry in Fine Shape: Stocks to Bet on Right Now
by Zacks Equity Research
Despite a few industry-related headwinds -- weak demand across agricultural and energy markets and sluggishness in China -- there are a number of reasons to be optimistic about the broader chemical industry for both the short and long haul.
Bear of the Day: The Andersons (ANDE)
by Tracey Ryniec
This Ohio agribusiness company is in turnaround mode as rails and fertilizers remain weak.
Cosan (CZZ) Q1 Earnings Fall Y/Y on Weak Sales, Margins
by Zacks Equity Research
Cosan Limited (CZZ) reported weak results for first-quarter 2017. Net income in the quarter was R$21.1 million (US$6.7 million), down 83.8% from the year-ago tally of R$130.3 million (US$33.3 million).
Chemical Industry Back on Track: Stocks Worth a Look
by Zacks Equity Research
Strength in the automotive sector and a rebound in non-residential construction and housing markets have helped pull the industry out of its funk.
$130 Billion Dow-DuPont Merger Finally Gains EU Approval
by Benjamin Rains
The European Union approved on Monday the proposed merger between The Dow Chemical Company (DOW) and E. I. du Pont de Nemours and Company (DD). The EU approval came after both Dow and DuPont committed to divest major portions of different businesses.
Syngenta's (SYT) 2016 Earnings Fall Y/Y, Outlook Positive
by Zacks Equity Research
Syngenta AG's (SYT) full-year 2016, diluted earnings per share, excluding restructuring and impairment charges, came in at $17.03 per share (or $3.4 per ADR), down 4.2% from $17.78 reported in the year-ago period.
Good Reasons to Bet on Chemical Stocks
by Zacks Equity Research
The shale gas revolution in the U.S. has been a huge driving force behind chemical investment on plants and equipment.